These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 579181)

  • 21. Persistent increase in bone turnover in Graves' patients with subclinical hyperthyroidism.
    Kumeda Y; Inaba M; Tahara H; Kurioka Y; Ishikawa T; Morii H; Nishizawa Y
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4157-61. PubMed ID: 11095447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum T3, T4, TSH patterns in euthyroid subjects treated with 131I for thyrotoxicosis.
    Biassoni P; Bagnasco M; Caputo M; Santaniello B; Ferrini O
    J Nucl Med Allied Sci; 1980; 24(1-2):93-8. PubMed ID: 7205396
    [No Abstract]   [Full Text] [Related]  

  • 23. Correlation between thyroxine, triiodothyronine and thyrotropin in geriatric patients with goitre.
    Varl B; Pavlin K
    Acta Med Austriaca; 1990; 17 Suppl 1():71-3. PubMed ID: 2389637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies of thyroid function and immune parameters in patients with hyperthyroid Graves' disease in remission.
    Murakami M; Koizumi Y; Aizawa T; Yamada T; Takahashi Y; Watanabe T; Kamoi K
    J Clin Endocrinol Metab; 1988 Jan; 66(1):103-8. PubMed ID: 3121661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transient recurrence of hyperthyroidism after delivery in Graves' disease.
    Amino N; Miyai K; Yamamoto T; Kuro R; Tanaka F
    J Clin Endocrinol Metab; 1977 Jan; 44(1):130-6. PubMed ID: 576228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum free thyroid hormones in T3-toxicosis: a study of 35 patients.
    Ferrari C; Romussi M; Rampini P; Benco R; Boghen M; Paracchi A; Frezzati S
    J Endocrinol Invest; 1983 Feb; 6(1):55-8. PubMed ID: 6687730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differentiation of thyrotoxicosis induced by thyroid destruction from Graves' disease.
    Amino N; Yabu Y; Miyai K; Fujie T; Azukizawa M; Onishi T; Kumahara Y
    Lancet; 1978 Aug; 2(8085):344-6. PubMed ID: 79711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pituitary-thyroid regulation in euthyroid patients with Graves' disease previously treated with antithyroid drugs.
    Buerklin EM; Schimmel M; Utiger RD
    J Clin Endocrinol Metab; 1976 Aug; 43(2):419-27. PubMed ID: 59733
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum triiodothyronine to thyroxine ratio: a newly recognized predictor of the outcome of hyperthyroidism due to Graves' disease.
    Takamatsu J; Kuma K; Mozai T
    J Clin Endocrinol Metab; 1986 May; 62(5):980-3. PubMed ID: 3754263
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The iodine perchlorate discharge test before and after one year of methimazole treatment of hyperthyroid Graves' disease.
    Roti E; Minelli R; Gardini E; Bianconi L; Salvi M; Gavaruzzi G; Ugolotti G; Braverman LE
    J Clin Endocrinol Metab; 1994 Mar; 78(3):795-9. PubMed ID: 8126159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thyroxine toxicosis in patients with iodine induced thyrotoxicosis.
    Sobrinho LG; Limbert ES; Santos MA
    J Clin Endocrinol Metab; 1977 Jul; 45(1):25-9. PubMed ID: 577497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thyroidal triiodothyronine and thyroxine in Graves' disease: correlation with presurgical treatment, thyroid status, and iodine content.
    Larsen PR
    J Clin Endocrinol Metab; 1975 Dec; 41(06):1098-104. PubMed ID: 54364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thyroid hormones homeostasis and TSH in autonomic thyroid nodule.
    Negoescu I; Simescu M; Constantinescu A
    Endocrinologie; 1978; 16(2):111-6. PubMed ID: 79214
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Study of the thyroid function by the I-M TRH test (2 mg) (author's transl)].
    Fournier M; Orgiazzi J; Magnon-Pujo B; Quintana J; Mornex R
    Ann Endocrinol (Paris); 1978; 39(1):59-60. PubMed ID: 418731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Value of routine serum-triiodothyronine estimation in diagnosis of thyrotoxicosis.
    Shalet SM; Beardwell CG; Lamb AM; Gowland E
    Lancet; 1975 Nov; 2(7943):1008-10. PubMed ID: 53496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thyroid function during pregnancy in women with past Graves' disease.
    Luton D; Le Gac I; Noel M; Guibourdenche J; Polak M
    BJOG; 2005 Nov; 112(11):1565-7. PubMed ID: 16225580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical study of Basedow's disease with T4 toxicosis].
    Shigemasa C
    Horumon To Rinsho; 1982 Jun; 30(6):603-9. PubMed ID: 6897024
    [No Abstract]   [Full Text] [Related]  

  • 38. [Impact of pretreatment variables on the outcome of standardized 131I therapy with 150 Gray in Graves' disease].
    Pfeilschifter J; Elser H; Haufe S; Ziegler R; Georgi P
    Nuklearmedizin; 1997 Apr; 36(3):81-6. PubMed ID: 9162906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves' hyperthyroidism.
    Roti E; Gardini E; Minelli R; Bianconi L; Salvi M; Gavaruzzi G; Braverman LE
    J Clin Endocrinol Metab; 1993 Apr; 76(4):928-32. PubMed ID: 7682562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The practical use of thyroid function tests.
    Feldman JM
    Am Fam Physician; 1977 Sep; 16(3):159-65. PubMed ID: 409266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.